Cite
HARVARD Citation
Tommerdahl, K. et al. (2022). The Role of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in the Prevention and Treatment of Diabetic Kidney Disease. Clinical journal of the American Society of Nephrology. 17 (6), pp. 905-907. [Online].